Abstract: The production process of the invention comprises a first step of hydrodesulfurizing of catalytically-cracked gasoline so as to result in an olefin hydrogenation rate of no greater than 25 mol % in the catalytically-cracked gasoline, a total sulfur content of no greater than 20 ppm by weight based on the product oil weight, a sulfur content derived from thiophenes and benzothiophenes of no greater than 5 ppm by weight and a sulfur content derived from thiacyclopentanes of no greater than 0.1 ppm by weight, and a second step of further hydrodesulfurizing of the product oil obtained by the first step so as to result in a total of no greater than 30 mol % for the olefin hydrogenation rate in the first step and the olefin hydrogenation rate in the second step, a total sulfur content of no greater than 10 ppm by weight based on the product oil weight, and a sulfur content derived from thiols of no greater than 5 ppm by weight.

Abstract: An oxidation catalyst is provided which is capable of combusting PM in a diesel engine exhaust gas at a low temperature and which has low degradation due to heat generated during combustion (i.e., has high heat resistance). A composite oxide for an exhaust gas purification catalyst is formed from Ce, Bi, R, R?, and oxygen, and when the molar ratios of Ce, Bi, R, and R? are expressed as Ce:Bi:R:R?=(1?x?y?z) :x:y:z, it satisfies 0<x?0.4, 0<y<1.0, and 0<z?0.5. Since this composite oxide has no change in its BET value even when treated at a high temperature, and can withstand a high amount of sulfur poisoning, retrogradation due to poisoning is low. Therefore, this exhaust gas purification catalyst is suitable as a PM combustion catalyst.

Abstract: Compounds represented by the Formula (A-1) and the Formula (1) or salt thereof are provided. The compounds represented by the Formula (A-1) and the Formula (1) or salt thereof have a ?3 adrenergic receptor agonist activity, and therefore are useful as an agent for the prevention and treatment of diabetes, obesity, hyperlipidemia, depression, biliary stone, a disorder derived from hyperactivity of biliary tract, a disorder derived from hyperactivity of digestive tract, interstitial cystitis, overactive bladder, urinary incontinence or a disorder derived from decreased tear secretion, etc.

Abstract: An object of an aspect of the present invention is to provide a method of producing a circuit board that allows highly accurate preservation of the circuit profile and gives a circuit having a desired depth in preparation of a fine circuit by additive process.

Abstract: A compound represented by the following general formula (I): wherein R1 represents an amino group which may be substituted with one or two alkyl groups; R2, R3, R4 and R5 independently represent an alkyl group; and R6 and R7 independently represent a monocarboxyalkyl group, a salt thereof, or an ester thereof, which is useful as a pH-sensitive fluorescent probe which emits intense fluorescence in an acidic region.

Abstract: An object of the invention is to provide a photoreceptor for electrophotography which has a low residual potential in an initial stage, is inhibited from increasing in residual potential, is prevented from decreasing in charge potential, and undergoes little fatigue deterioration even upon repeated use. The invention relates to a photoreceptor for electrophotography which has a photosensitive layer containing a cyclic phenol sulfide represented by the following general formula (1): and one or more charge-transporting agents each having an arylamino group in the molecule, and which has excellent durability.

Abstract: A multilayered board including a material board having a visible surface coated with at least one paper layer impregnated with resin. The multilayered board includes a material board, at least one paper layer structured to coat the material board, and a resin layer structured to impregnate the at least one paper layer, wherein the resin layer is arranged to face away from the material board and have an average layer thickness of at least 5 ?m.

Abstract: Window element (1, 23) with a covering tape (7, 36) and a covering means (8, 35) and comprising a window assembly (5, 25) which can be fixed in a hermetically sealed manner to the window frame (4, 24) by means of a retainer (15, 26), the window frame (4, 24) being enclosed by an encircling seal (11, 32) which has an encircling recess (12, 33).

Abstract: The invention is directed to a material and method for obtaining a ceramic abradable system for high temperature applications. High purity partially stabilized zirconia and/or hafnia base material has higher sintering resistance compared to conventional 6-9 weight percent yttria stabilized zirconia systems. The benefits of these systems are higher service lifetime and low thermal conductivity to achieve high operating temperatures. System includes a superalloy substrate, oxidation resistant bond coat and a thick ceramic abradable top coat. Total coating thickness is about 0.5-5 mm. In some applications an intermediate layer of high purity partially stabilized zirconia or a partially stabilized YSZ/MCrAlY cermet is applied over the oxidation resistant bond coat. In other applications an abradable system is applied on top of a grid. Additional benefits should be reduced blade wear at high operating conditions.

Abstract: A substrate having an anti-adhesive coating thereon. The coating is made from a coating composition comprising solid particles of a release agent different from boron nitride and a binder comprising surface-modified nanoscale solid particles.

Abstract: The invention relates to antibodies for use for modulating the activity of the lysine-specific demethylase (LSD1) in a mammal and to pharmaceutical and diagnostical compositions comprising such antibodies. The invention also relates to a method for identifying and/or scoring prostate carcinomas. Furthermore, the invention relates to the use of at least one siRNA (“short interfering RNA”) and/or at least one anti-LSD1 antibody for modulating the activity of the lysine-specific demethylase (LSD1) in a mammal or for the manufacture of a medicament for modulating the activity of the lysine-specific demethylase (LSD1) in a mammal. The invention also relates to a pharmaceutical composition for controlling the androgen receptor-dependent gene expression, comprising an effective dose of at least one siRNA and/or at least one anti-LSD1 antibody suitable for modulating the activity of the lysine-specific demethylase (LSD1) in a mammal.

Abstract: Conventional I-form crystals of 5-hydroxy-1-methylhydantoin contain, remaining therein in a considerable amount, the organic solvent used in a purification step. In contrast, in II-form crystals, the amount of the organic solvent remaining therein is smaller than the detection limit. Namely, the II-form crystals contain substantially no residual organic solvent. The novel II-form crystals of 5-hydroxy-1-methylhydantoin obtained through recrystallization from water not only contain substantially no residual organic solvent, but also have a high bulk density and are hence advantageous for pharmaceutical preparation. They further have properties advantageous for production, such as low adhesion. The crystals are significantly useful as a material for medicines required to have high safety, such as drugs for renal insufficiency.

Abstract: Post-foaming cosmetic cleansing preparation on an aqueous basis which is suitable for dispensing from an aerosol container, containing in a conventional aqueous base preparation a) detersive surfactants with saturated radicals, preferably anionic surfactants and non-ionic surfactants and/or amphoteric surfactants, b) 2.5 to 25% by volume, preferably 5 to 20% by volume, particularly preferably 7.5 to 15% by volume of pure oxygen.

Abstract: Cosmetic or dermatological compositions which comprise at least one piperidinium salt, preferably a 4-[(2-cyclopentyl-2-hydroxyphenylacetyl)oxy]-1,1-dimethyl-piperidinium salt, and the use thereof, particularly as antiperspirants. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.

Abstract: A syringe has a barrel to receive a cartridge. The barrel has a front end portion to which a needle is connected for engagement with the cartridge. At its rear end, the barrel has a plunger mechanism. A sleeve is slidably mounted on the barrel and can be pushed forwards to sheath the needle. The needle is mounted on the barrel via a push-fit mounting device. The needle can be removed for disposal in a container by inserting the syringe into a tube on top of the container so that the protective needle sleeve is pushed back and the needle and mounting device pass through a collar of gripping fingers at an inner end of the tube. The fingers catch behind the mounting device so that this is pulled off to drop into the container with the needle when the syringe is withdrawn from the tube.

Abstract: A scavenger of superoxide anion or nitric oxide comprising finepowder of a transition metal such as platinum. The scavenger is preferably provided as an aqueous solution containing transition metal colloid at a ratio of 1 mM or less per 1,000 ml, and can efficiently eliminate excessive superoxide anions or nitric oxide in vivo.

Abstract: A self-adhesive polymer matrix which comprises a polymer that forms a gel in water, water, a sea algae extract, and a monohydric or polyhydric alcohol.

Abstract: A self-adhesive polymer matrix which comprises a polymer that forms a gel in water, water, a sea algae extract, and a monohydric or polyhydric alcohol.

Abstract: A cosmetic or pharmaceutical preparation comprising licochalcone A and one or more hydrocolloids. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way.

Abstract: Substrates with a biofilm-inhibiting coating comprising an inorganic condensate modified with organic groups, at least some of the organic groups of the condensate containing fluorine atoms and the coating comprising copper colloids or silver colloids.